BiykemBozkurt(@BiykemB) 's Twitter Profileg
BiykemBozkurt

@BiykemB

Editor-in-Chief JACC:HF, Senior Dean of Faculty, Baylor College of Medicine, Cain Chair, Prof of Med & Director of Winters Ctr for Heart Failure, Mother of 3

ID:1025948047707127809

calendar_today05-08-2018 03:34:10

3,4K Tweets

5,1K Followers

1,4K Following

Muthu Vaduganathan(@mvaduganathan) 's Twitter Profile Photo

.JACC Journals reference pocket cards for contemporary global guideline recommendations for drugs & devices in HF across the LVEF spectrum.🗒️

jacc.org/doi/10.1016/j.…

.@JACCJournals reference pocket cards for contemporary global guideline recommendations for drugs & devices in HF across the LVEF spectrum.🗒️ jacc.org/doi/10.1016/j.…
account_circle
HF Collaboratory(@hfcollaboratory) 's Twitter Profile Photo

Congrats to Dr. Norman Stockbridge on receiving the Lifetime Achievement Award🏆

Dr. Stockbridge has made impressive contributions to the CV research & regulatory arena making a significant impact on the way clinical trials are conducted.
No one is more deserving of this award!

Congrats to Dr. Norman Stockbridge on receiving the Lifetime Achievement Award🏆 Dr. Stockbridge has made impressive contributions to the CV research & regulatory arena making a significant impact on the way clinical trials are conducted. No one is more deserving of this award!
account_circle
Muthu Vaduganathan(@mvaduganathan) 's Twitter Profile Photo

by Alberto Foà in JACC Journals

Fascinating observation from — pts w LVEF above 60% were at *higher* risk of hypotension & *lower* likelihood of benefit w sacubitril/valsartan

Reinforces current guidance for pt selection

jacc.org/doi/10.1016/j.…

#ACC24 #SimPub by @FoaAlberto in @JACCJournals Fascinating observation from #PARAGONHF — pts w LVEF above 60% were at *higher* risk of hypotension & *lower* likelihood of benefit w #ARNI sacubitril/valsartan Reinforces current guidance for pt selection jacc.org/doi/10.1016/j.…
account_circle
JACC Journals(@JACCJournals) 's Twitter Profile Photo

Analysis of trial shows that beta-blocker use wasn't linked to or . Benefits of remained consistent regardless of beta-blockers, reassuring their role in treating or alongside . bit.ly/4b2jQCQ

Analysis of #DELIVER trial shows that beta-blocker use wasn't linked to #worseningHF or #cvDeath. Benefits of #dapagliflozin remained consistent regardless of beta-blockers, reassuring their role in treating #HFpEF or #HFmrEF alongside #SGLT2i. bit.ly/4b2jQCQ #JACCHF
account_circle
JACC Journals(@JACCJournals) 's Twitter Profile Photo

Quadruple therapy w/ , BB, MRA, led to decreased risk of CV death & HHF in pts w/ & . This benefit is largely driven by ARNI, MRA, SGLT2i, which was more pronounced in HFmrEF. bit.ly/3UtIEOD

Stefanos Zafeiropoulos, MD, MS, PhD George Giannakoulas

Quadruple therapy w/ #ARNI, BB, MRA, #SGLT2i led to decreased risk of CV death & HHF in pts w/ #HFmrEF & #HFpEF. This benefit is largely driven by ARNI, MRA, SGLT2i, which was more pronounced in HFmrEF. bit.ly/3UtIEOD #JACCHF #GDMT #CHF @Cardiaficionado @GGiannakoulas
account_circle
Novi Tham(@slumberbell) 's Twitter Profile Photo

use in and

In this month’s issue of , analysis of trial shows:

♥️ 4 out of 5 px were treated with
♥️ use wasn't linked to or
♥️Benefits of remained consistent regardless of
➡️➡️

#BetaBlocker use in #HFpEF and #HFmrEF❓ In this month’s issue of #JACCHF, analysis of #DELIVER trial shows: ♥️ 4 out of 5 px were treated with #BB ♥️#BB use wasn't linked to #worseningHF or #CVdeath ♥️Benefits of #Dapagliflozin remained consistent regardless of #BB ➡️➡️
account_circle
Shahnawaz Amdani(@ShaanAmdani) 's Twitter Profile Photo

2.  All tiers except adult rating for FT had poor agreement/consistency across the study period. In addition, the ratings had poor reliability.

2.  All tiers except adult rating for FT had poor agreement/consistency across the study period. In addition, the ratings had poor reliability.
account_circle
Shahnawaz Amdani(@ShaanAmdani) 's Twitter Profile Photo

Transplant Center performance is reported in public domain in United States? We reviewed their stability, volatility and reliability for pediatric and adult heart transplant centers.

JACC Journals : jacc.org/doi/10.1016/j.…

Cleveland Clinic Heart, Vascular & Thoracic BiykemBozkurt

A 🧵:

Transplant Center performance is reported in public domain in United States? We reviewed their stability, volatility and reliability for pediatric and adult heart transplant centers. @JACCJournals : jacc.org/doi/10.1016/j.… @CleClinicHVTI @BiykemB A 🧵:
account_circle
Nikhil Narang, MD(@Nikhil15) 's Twitter Profile Photo

New work in JACC Journals on the treatment effects of ICDs for patients with chronic HFrEF—baseline frailty status significantly modifies risk of all-cause mortality in this large cohort from SCD-HeFT Matt Segar Neil Keshvani ambarish

📎 tinyurl.com/57z4fhfy

New work in @JACCJournals #JACCHF on the treatment effects of ICDs for patients with chronic HFrEF—baseline frailty status significantly modifies risk of all-cause mortality in this large cohort from SCD-HeFT @MattSegar @NeilKeshvani @ambarish4786 📎 tinyurl.com/57z4fhfy
account_circle
Gregg Fonarow MD(@gcfmd) 's Twitter Profile Photo

Benefits of rapid initiation of quadruple GDMT new diagnosed HFrEF

12 month mortality rates

Quad GDMT vs no GDMT
ARR 24.8%, NNT=4

Quad GDMT vs ACEI/ARB+BB
ARR 10.4%, NNT=10

sciencedirect.com/science/articl…

Benefits of rapid initiation of quadruple GDMT new diagnosed HFrEF 12 month mortality rates Quad GDMT vs no GDMT ARR 24.8%, NNT=4 Quad GDMT vs ACEI/ARB+BB ARR 10.4%, NNT=10 sciencedirect.com/science/articl…
account_circle
Steve Greene(@SJGreene_md) 's Twitter Profile Photo

🚨New in JACC Journals w

🇺🇸 analysis of newly diagnosed

>4 in 5 pts eligible for quad GDMT

Yet, <1 in 6 prescribed it.

Potentially completely generic triple GDMT (RASi + BB + MRA)??.....only ~4 in 10 eligible pts even prescribed this.

jacc.org/doi/10.1016/j.…

🚨New in @JACCJournals w #ACC24 🇺🇸 analysis of newly diagnosed #HFrEF >4 in 5 pts eligible for quad GDMT Yet, <1 in 6 prescribed it. Potentially completely generic triple GDMT (RASi + BB + MRA)??.....only ~4 in 10 eligible pts even prescribed this. jacc.org/doi/10.1016/j.…
account_circle
Umair Khalid(@Umair2017) 's Twitter Profile Photo

Meet the incredible IC Family of VA Houston! 🎉 Huge shoutout to Ali Denktas (my amazing mentor), Jing Liu, MD & Syed Zaid, MD 🌟

Had a challenging case: 82-year-old male, last vessel with +++ Ca (needed Rota-Shock), LVEF 10-15%, significant PAD.

Of course, the IC fellow was off

Meet the incredible IC Family of VA Houston! 🎉 Huge shoutout to @AliDenktasMD (my amazing mentor), @JingLiu_MD & @SyedZaidMD 🌟 Had a challenging case: 82-year-old male, last vessel with +++ Ca (needed Rota-Shock), LVEF 10-15%, significant PAD. Of course, the IC fellow was off
account_circle